Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination

With the ongoing COVID-19 pandemic and the emergence of various SARS-CoV-2 variants, a comprehensive evaluation of long-term efficacy of antibody response in convalescent individuals is urgently needed. Several longitudinal studies had reported the antibody dynamics after SARS-CoV-2 acute infection,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Miao, Zhou, Bing, Fan, Qing, Zhou, Xinrong, Liao, Xuejiao, Lin, Jingyan, Ma, Zhenghua, Dong, Jingke, Wang, Haiyan, Ge, Xiangyang, Ju, Bin, Zhang, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809350/
https://www.ncbi.nlm.nih.gov/pubmed/36444724
http://dx.doi.org/10.1080/22221751.2022.2151381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809350/
https://www.ncbi.nlm.nih.gov/pubmed/36444724
http://dx.doi.org/10.1080/22221751.2022.2151381

Ejemplares similares